Малайзія -
англійська -
NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
pentasa suppositories 1g
ferring sdn. bhd. - 5-amino salicylic acid(5-asa),mesalazine -
Австралія -
англійська -
Department of Health (Therapeutic Goods Administration)
salofalk granules mesalazine 1g modified release granules sachet
dr falk pharma australia pty ltd - mesalazine, quantity: 1000 mg - granules, modified release - excipient ingredients: simethicone; aspartame; microcrystalline cellulose; triethyl citrate; colloidal anhydrous silica; citric acid; carmellose sodium; magnesium stearate; purified talc; titanium dioxide; povidone; methacrylic acid copolymer; hypromellose; flavour - salofalk granules are indicated for the treatment of acute ulcerative colitis of mild to moderate severity, and for the maintenance of remission and/or the long term treatment of ulcerative colitis.
Австралія -
англійська -
Department of Health (Therapeutic Goods Administration)
salofalk granules mesalazine 500mg modified release granules sachet
dr falk pharma australia pty ltd - mesalazine, quantity: 500 mg - granules, modified release - excipient ingredients: colloidal anhydrous silica; purified talc; povidone; aspartame; titanium dioxide; methacrylic acid copolymer; magnesium stearate; triethyl citrate; microcrystalline cellulose; carmellose sodium; simethicone; citric acid; hypromellose; flavour - salofalk granules are indicated for the treatment of acute ulcerative colitis of mild to moderate severity, and for the maintenance of remission and/or the long term treatment of ulcerative colitis.
Австралія -
англійська -
Department of Health (Therapeutic Goods Administration)
salofalk mesalazine 1g enteric coated tablet, blister pack
dr falk pharma australia pty ltd - mesalazine, quantity: 1 g - tablet, enteric coated - excipient ingredients: povidone; microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; calcium stearate; hypromellose; methacrylic acid copolymer; purified talc; titanium dioxide; iron oxide yellow; macrogol 6000 - salofalk tablets are indicated in the treatment of acute episodes and maintenance of remission of: i. mild to moderate ulcerative colitis; and ii. crohn?s ileitis and colitis
Ізраїль -
англійська -
Ministry of Health
rafassal 1 gram granules
rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - granules prolonged release gastro resistant - mesalazine (5 - aminosalicylic acid) 1 g - mesalazine - for the treatment of acute episodes and the maintenance of remission of ulcerative colitis.
Ізраїль -
англійська -
Ministry of Health
rafassal 1 gram granules
rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - granules prolonged release gastro resistant - mesalazine (5 - aminosalicylic acid) 1 g - mesalazine - for the treatment of acute episodes and the maintenance of remission of ulcerative colitis.
Ізраїль -
англійська -
Ministry of Health
rafassal 1.5 gram granules
rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - granules prolonged release gastro resistant - mesalazine (5 - aminosalicylic acid) 1.5 g - mesalazine - for the treatment of acute episodes and the maintenance of remission of ulcerative colitis.
Ізраїль -
англійська -
Ministry of Health
rafassal 1.5 gram granules
rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - granules prolonged release gastro resistant - mesalazine (5 - aminosalicylic acid) 1.5 g - mesalazine - for the treatment of acute episodes and the maintenance of remission of ulcerative colitis.
Ізраїль -
англійська -
Ministry of Health
rafassal 3 gram granules
rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - granules prolonged release gastro resistant - mesalazine (5 - aminosalicylic acid) 3 g - mesalazine - for the treatment of acute episodes and the maintenance of remission of ulcerative colitis.
Ізраїль -
англійська -
Ministry of Health
rafassal 1 gram granules
rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - granules prolonged release gastro resistant - mesalazine (5 - aminosalicylic acid) 1 g - mesalazine - for the treatment of acute episodes and the maintenance of remission of ulcerative colitis.